tiprankstipranks
Trending News
More News >

OncoSil Medical Advances in German Market with New Study Tender

Story Highlights
  • OncoSil Medical specializes in cancer treatment devices, focusing on pancreatic cancer.
  • A new study in Germany could enhance OncoSil’s market positioning and treatment guidelines inclusion.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
OncoSil Medical Advances in German Market with New Study Tender

Confident Investing Starts Here:

OncoSil Medical Ltd ( (AU:OSL) ) has provided an announcement.

OncoSil Medical Limited has announced that the Federal Joint Committee in Germany has initiated a tender process to select a Contract Research Organisation for a study on the OncoSil™ device. This study will evaluate the device’s effectiveness in combination with chemotherapy for treating unresectable, locally advanced pancreatic cancer. This development is a significant step towards potential inclusion in German treatment guidelines and the statutory health insurance system, which could impact the company’s market positioning and stakeholder interests.

More about OncoSil Medical Ltd

OncoSil Medical Limited is a company specializing in cancer treatment devices, particularly the OncoSil™ brachytherapy device used for treating locally advanced unresectable pancreatic cancer. The device delivers targeted intratumoral placement of Phosphorous-32 in combination with chemotherapy. It has received breakthrough device designation in the EU, UK, and US, and is approved for sale in over 30 countries.

Technical Sentiment Signal: Buy

Current Market Cap: A$23.03M

For a thorough assessment of OSL stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1